Novo Nordisk Aware of 10 Deaths, 100 Hospitalizations Linked to Mounjaro; UK Reports First Fatality of 58-Year-Old Nurse

Nov 8, 2024, 08:16 AM

Novo Nordisk has acknowledged reports of 10 deaths and 100 hospitalizations associated with compounded versions of its weight-loss and diabetes medications. The situation has escalated following the death of a 58-year-old nurse in the UK, which is the first reported fatality linked to the NHS-approved weight-loss drug Mounjaro. The nurse reportedly fell ill after receiving two low-dose injections of the drug. Patients have since come forward to describe severe side effects from Mounjaro, expressing regret over their use of the medication as the UK continues to investigate the implications of these incidents.